Aelis Farma SA (AELIS.PA)
EUR 1.24
(1.23%)
EUR 1.24
(1.23%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.39 EUR | 67.77% |
| 2022 | -1.21 EUR | -2123.41% |
| 2021 | 0.06 EUR | 127.18% |
| 2020 | -0.22 EUR | 35.29% |
| 2019 | -0.34 EUR | -21.43% |
| 2018 | -0.28 EUR | -166.67% |
| 2017 | -0.10 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.14 EUR | 0.0% |
| 2024 Q1 | -0.14 EUR | -7.69% |
| 2023 Q2 | -0.13 EUR | -100.0% |
| 2023 FY | - EUR | 67.77% |
| 2023 Q3 | -0.14 EUR | -7.69% |
| 2023 Q1 | -0.06 EUR | 79.03% |
| 2023 Q4 | -0.13 EUR | 7.14% |
| 2022 Q2 | -0.93 EUR | -97.87% |
| 2022 Q4 | -0.31 EUR | -93.75% |
| 2022 FY | - EUR | -2123.41% |
| 2022 Q1 | -0.47 EUR | -176.47% |
| 2022 Q3 | -0.16 EUR | 82.8% |
| 2021 Q2 | 0.16 EUR | 0.0% |
| 2021 Q1 | 0.16 EUR | 545.68% |
| 2021 FY | - EUR | 127.18% |
| 2021 Q4 | -0.17 EUR | 0.0% |
| 2021 Q3 | -0.17 EUR | -206.25% |
| 2020 Q2 | -0.07 EUR | 0.0% |
| 2020 Q1 | -0.07 EUR | 0.0% |
| 2020 FY | - EUR | 35.29% |
| 2020 Q4 | -0.04 EUR | 0.0% |
| 2020 Q3 | -0.04 EUR | 50.75% |
| 2019 FY | - EUR | -21.43% |
| 2018 FY | - EUR | -166.67% |
| 2017 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -225.0% |
| ABIVAX Société Anonyme | -3.43 EUR | 88.63% |
| Adocia SA | -1.91 EUR | 79.581% |
| Biophytis S.A. | -12.55 EUR | 96.892% |
| Advicenne S.A. | -0.67 EUR | 41.791% |
| genOway Société anonyme | 0.17 EUR | 329.412% |
| IntegraGen SA | -0.03 EUR | -1405.792% |
| Medesis Pharma S.A. | -0.80 EUR | 51.25% |
| Neovacs S.A. | -0.00 EUR | -15500.0% |
| NFL Biosciences SA | -0.46 EUR | 15.217% |
| Plant Advanced Technologies SA | 0.07 EUR | 657.143% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -328.571% |
| Sensorion SA | -0.17 EUR | -129.412% |
| Theranexus Société Anonyme | -0.88 EUR | 55.682% |
| TME Pharma N.V. | -1.34 EUR | 70.896% |
| Valbiotis SA | -0.59 EUR | 33.898% |
| TheraVet SA | -0.49 EUR | 20.408% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -160.0% |
| DBV Technologies S.A. | -0.71 EUR | 45.07% |
| Genfit S.A. | -0.58 EUR | 32.759% |
| GeNeuro SA | -0.59 EUR | 33.898% |
| Innate Pharma S.A. | -0.09 EUR | -314.453% |
| Inventiva S.A. | -2.43 EUR | 83.951% |
| MaaT Pharma SA | -1.73 EUR | 77.457% |
| MedinCell S.A. | -0.88 EUR | 55.682% |
| Nanobiotix S.A. | -1.08 EUR | 63.889% |
| OSE Immunotherapeutics SA | -1.18 EUR | 66.949% |
| Poxel S.A. | -0.91 EUR | 57.143% |
| GenSight Biologics S.A. | -0.54 EUR | 27.778% |
| Transgene SA | -0.22 EUR | -77.273% |
| Valneva SE | -0.73 EUR | 46.575% |